Delivery Order SPE2DB22D2007-SPE2DB25FJ0JS
Award Date
4/2/25
Potential Completion Date
4/23/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $10,916.78, is a delivery order for the product "PHESGO 600-600 MG-20,000 UNIT 10ML" with a performance period ending on March 19, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,916.78 delivery order contract is for the supply of the drug product PHESGO 600-600 MG-20,000 UNIT 10ML. The contract is a firm fixed price, Delivery Order type and does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen holds...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,916.78, is for the delivery of the product "PHESGO 600-600 MG-20,000 UNIT 10ML." This is a firm fixed-price delivery order contract with an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $10,641.84 and is a delivery order for the supply of PHESGO 600-600 mg-20,000 unit 10 ml medical products. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award value of $10,916.78 and is a firm fixed-price delivery order that runs through March 2025. The contract covers the provision of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product, to support federal healthcare programs, particularly military and veterans' healthcare systems. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,833.56 firm fixed price contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen is the prime contractor, and there is no set-aside designation indicated. The contract is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products. The award, valued at $63,851.04, is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 9, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and will be supplying a variety of medical commodities, including PHESGO 600-600...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,458.39, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceuticals. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $10,641.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PHESGO, a medical product, with a completion date of October 7, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA, potentially worth up to $999,999,999, for the supply of a broad range of medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 600-600 mg - 20,000 unit 10 ml of the pharmaceutical product PHESGO. The award, valued at $21,283.68, has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under any set-aside designation. This delivery order is part of a larger indefinite delivery contract...